Most cultured cells spend their entire life sitting in far more oxygen than they would ever encounter in the body. A standard CO2 incubator holds cells at around 18% oxygen, while human tissues typically sit between 2% and 6%.¹ That gap is easy to overlook because it’s invisible in the data, but it can quietly shape how cells behave, and by extension, how trustworthy the resulting data actually is.
Why oxygen level matters in the first place
“Oxygen determines how cells behave at every level, making careful control in culture essential,” says Derek Sokolowski, Product Manager, Cell Culture at PHC Corporation of North America, supplier of PHCbi laboratory solutions. Cells continuously rebalance between glycolysis and oxidative phosphorylation based on how much extracellular oxygen is available, Sokolowski explains, so any readout downstream of energy metabolism shifts along with it. Oxygen tension also affects stem cell behavior: low oxygen tends to help maintain many stem cell types in their undifferentiated state, while excess oxygen can push them toward differentiation depending on context. Surplus oxygen additionally drives the production of reactive oxygen species, which can damage DNA and contribute to premature cellular senescence. And because oxygen alters the signaling pathways that many compounds depend on, a drug can appear effective in a standard culture dish and behave quite differently once it reaches tissue.
Where the mismatch causes the most trouble
“Under standard incubation conditions, a phenotype or drug response measured in culture may not hold the same effect in tissue,” Sokolowski says, “which means findings that look solid in vitro may fail to translate realistically in patients.” This isn’t an argument that conventional incubation is wrong so much as a reminder that it represents one specific, often supraphysiological, condition, one worth matching deliberately to the research question rather than defaulting to automatically.
Which research benefits most from hypoxic incubation
Not every experiment needs low-oxygen conditions, but some fields depend on them more than others. “The research that benefits most from hypoxic incubation is the work where low oxygen is part of how the cells normally function,” Sokolowski says. Stem cell research is a clear example: niches such as bone marrow sit at roughly 1–7% oxygen,² and recreating that environment can help keep stem cells undifferentiated longer, preserving potency and yielding more usable cells by the end of a run.
Cardiovascular research shows a similar pattern. Physiological oxygen tension in heart tissue is around 5%, yet cardiac progenitor cells are conventionally cultured at 21%.³ Cardiac mesenchymal cells cultured at the lower oxygen levels have shown improved morphology, increased proliferation rate, and better resistance to hypoxic stress, Sokolowski notes, traits that matter for cell therapy applications where transplanted cells need to survive in damaged, low-oxygen tissue.
Cancer research benefits as well, since tumors are hypoxic by nature; replicating that environment gives a more representative picture of tumor behavior than standard culture can. “Similar arguments apply in immunology, neuroscience, and organoid work, among others,” Sokolowski adds. “In each case, the benefit comes from matching oxygen levels to what the cells would encounter in the body rather than to what a standard incubator provides.”
A common misconception: the chamber isn’t the culture
One assumption trips up even experienced researchers. “Regardless of the chamber’s oxygen level, researchers often assume the oxygen content in the cell culture itself matches it,” Sokolowski says.⁴ “Realistically, the levels of oxygen at the surface of a culture may be completely different from the levels experienced toward the bottom of the plate, creating variability that can impact experiment reproducibility.” He points to cell density, medium depth, and allowing enough time for the medium to equilibrate before starting an experiment as the main levers researchers can use to manage that variability.
Matching the method to the question
None of this means hypoxic incubation should replace standard culture outright. As Zachary Rogers, a postdoctoral fellow at MIT’s Koch Institute for Integrative Cancer Research, explained in a separate Biocompare article on oxygen control in cell culture, oxygen control is best treated as a tool suited to specific experiments rather than a universal upgrade. Reoxygenation when plates leave a hypoxic environment can itself generate reactive oxygen species and destabilize hypoxia-related signaling, and sustained low-oxygen culture isn’t always practical for long experiments. The more useful question, he suggests, isn’t whether to adopt oxygen control, but which oxygen level a given experiment actually needs, and how gas-phase settings relate to the oxygen cells experience locally.
For a side-by-side look at incubator types, including standard, CO2, and hypoxic systems, Biocompare’s Guide to Laboratory Incubators is a useful starting point. Researchers who want to go deeper into the physiological case for low-oxygen culture can also read Biocompare’s eBook, Transforming Cell Culture with Low Oxygen: The Critical Case for Physioxia.
References
1. Alva, Ricardo, Georgina L. Gardner, Ping Liang, and Jeffrey A. Stuart. 2022. “Supraphysiological Oxygen Levels in Mammalian Cell Culture: Current State and Future Perspectives” Cells 11, no. 19: 3123.
2. Tsai CC, Yew TL, Yang DC, Huang WH, Hung SC. Benefits of hypoxic culture on bone marrow multipotent stromal cells. Am J Blood Res. 2012;2(3):148-59. PMID: 23119226.
3. Bolli RA, Dasari C, Arshia A, Devadoss D, Guo Y, Ashraf U, Li Q. Physiological Oxygen Tension Enhances Competence and Functional Properties of Murine Cardiac Mesenchymal Cells. Stem Cell Rev Rep. 2021 Jun;17(3):900-910.
4. Place TL, Domann FE, Case AJ. Limitations of oxygen delivery to cells in culture: An underappreciated problem in basic and translational research. Free Radic Biol Med. 2017 Dec;113:311-322. doi: 10.1016/j.freeradbiomed.2017.10.003. Epub 2017 Oct 13. Erratum in: Free Radic Biol Med. 2021 Jan;162:180.